Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

U.S. futures edge higher ahead of jobs data; Dow Jones up 0.08%

Published 04/03/2013, 06:50 AM
Updated 04/03/2013, 06:51 AM

Investing.com - U.S. stock futures pointed to a moderately higher open on Wednesday, as investors awaited the release of U.S. jobs data later in the day, while concerns over the financial situation in the euro continued to weigh.

Ahead of the open, the Dow Jones Industrial Average futures pointed to a 0.08% gain, S&P 500 futures signaled a 0.14% increase, while the Nasdaq 100 futures indicated a 0.12% rise.

Markets were jittery after data on Tuesday showed that the euro zone’s manufacturing purchasing managers’ index fell to 46.8 in March, from a final reading of 47.9 the previous month, still substantially below the 50 mark that separates growth from contraction.

Separately, Reuters reported that international lenders have given Cyprus until 2018 to meet new budget targets, including freezing public sector pensions, raising taxes and hiking public sector fees.

The Cypriot Finance Minister Michael Sarris resigned on Tuesday after wrapping up bailout talks with lenders.

Telecom stocks were expected to be active, after Verizon said it does not "currently have any intention" to merge with or buy its partner Vodafone, either alone or in conjunction with others, in response to Tuesday's Financial Times report.

However, the company said that it would still be a willing buyer of Vodafone's 45% share of their Verizon Wireless U.S. venture. Verizon shares dropped 0.48% in after-hour trade.

Pharmaceuticals were also likely to be in focus, amid reports at least three of the world's top drugmakers - Pfizer, Novartis and Abbott Laboratories - are bidding for Brazil's Ache Laboratorios Farmaceuticos in an auction that could value the group at more than USD5 billion

Also in M&A news, Thermo Fisher Scientific was said to be emerging as the lead contender in an auction for Life Technologies, a genetic testing maker.

Elsewhere, Tesla Motors plummeted 2.57% in early trading, after saying late Tuesday that it was partnering with Wells Fargoand U.S. Bank on a financing product that it says will make its pricey electric sedan accessible to more people.

Among retailers, J.C. Penney was set to be in focus, as Chief Executive Ron Johnson received total compensation of USD1.9 million in 2012, marking a sharp decline.

Across the Atlantic, European stock markets were lower. The EURO STOXX 50 slipped 0.27%, France’s CAC 40 edged down 0.11%, Germany's DAX fell 0.12%, while Britain's FTSE 100 declined 0.41.

During the Asian trading session, Hong Kong's Hang Seng Index slipped 0.14%, while Japan’s Nikkei 225 Index surged 2.99%.

Later in the day, the U.S. was to release the ADP nonfarm payrolls report, while the Institute of Supply Management was release a report on U.S. service sector activity.


Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.